Structural Insight into the Constitutive Repression Function of the Nuclear Receptor Rev-erbβ

Journal of Molecular Biology

Volumn 373, Issue 3, 2007, Pages 735-744

  Woo, Eui Jeon ^a   Jeong, Dae Gwin ^a   Lim, Mi Youn ^a   Jun Kim, Seung ^a   Kim, Kyung Jin ^b   Yoon, Sei Mee ^a   Park, Byoung Chul ^a   Eon Ryu, Seong ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

constitutive repression; crystal structure; ligand binding domain; orphan receptor; Rev erb

Indexed keywords

CELL NUCLEUS RECEPTOR; CELL NUCLEUS RECEPTOR REV ERB BETA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; HYDROPHOBICITY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STRUCTURE;

EID: 34748836883     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.08.037     Document Type: Article

References (53)

1. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895
2. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., et al. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
3. Escriva H., Safi R., Hanni C., Langlois M.C., Saumitou-Laprade P., Stehelin D., et al. Ligand binding was acquired during evolution of nuclear receptors. Proc. Natl Acad. Sci. USA 94 (1997) 6803-6808
4. Lazar M.A., Hodin R.A., Darling D.S., and Chin W.W. A novel member of the thyroid/steroid hormone receptor family is encoded by the opposite strand of the rat c-erbA alpha transcriptional unit. Mol. Cell. Biol. 9 (1989) 1128-1136
5. Dumas B., Harding H.P., Choi H.S., Lehmann K.A., Chung M., Lazar M.A., and Moore D.D. A new orphan member of the nuclear hormone receptor superfamily closely related to Rev-Erb. Mol. Endocrinol. 8 (1994) 996-1005
6. Forman B.M., Chen J., Blumberg B., Kliewer S.A., Henshaw R., Ong E.S., and Evans R.M. Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors. Mol. Endocrinol. 8 (1994) 1253-1261
7. Delerive P., Chin W.W., and Suen C.S. Identification of Reverb(alpha) as a novel ROR(alpha) target gene. J. Biol. Chem. 277 (2002) 35013-35018
8. Adelmant G., Begue A., Stehelin D., and Laudet V. A functional Rev-erb alpha responsive element located in the human Rev-erb alpha promoter mediates a repressing activity. Proc. Natl. Acad. Sci. USA 93 (1996) 3553-3558
9. Miyajima N., Horiuchi R., Shibuya Y., Fukushige S., Matsubara K., Toyoshima K., and Yamamoto T. Two erbA homologs encoding proteins with different T3 binding capacities are transcribed from opposite DNA strands of the same genetic locus. Cell 57 (1989) 31-39
10. Zamir I., Zhang J., and Lazar M.A. Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev. 11 (1997) 835-846
11. Harding H.P., and Lazar M.A. The monomer-binding orphan receptor Rev-Erb represses transcription as a dimer on a novel direct repeat. Mol. Cell. Biol. 15 (1995) 4791-4802
12. Guillaumond F., Dardente H., Giguere V., and Cermakian N. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J. Biol. Rhythms 20 (2005) 391-403
13. Balsalobre A., Damiola F., and Schibler U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93 (1998) 929-937
14. Torra I.P., Tsibulsky V., Delaunay F., Saladin R., Laudet V., Fruchart J.C., et al. Circadian and glucocorticoid regulation of Rev-erbalpha expression in liver. Endocrinology 141 (2000) 3799-3806
15. Sato T.K., Panda S., Miraglia L.J., Reyes T.M., Rudic R.D., McNamara P., et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 43 (2004) 527-537
16. Preitner N., Damiola F., Lopez-Molina L., Zakany J., Duboule D., Albrecht U., and Schibler U. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 110 (2002) 251-260
17. Triqueneaux G., Thenot S., Kakizawa T., Antoch M.P., Safi R., Takahashi J.S., et al. The orphan receptor Rev-erbalpha gene is a target of the circadian clock pacemaker. J. Mol. Endocrinol. 33 (2004) 585-608
18. Ramakrishnan S.N., Lau P., Burke L.J., and Muscat G.E. Rev-erbbeta regulates the expression of genes involved in lipid absorption in skeletal muscle cells: evidence for cross-talk between orphan nuclear receptors and myokines. J. Biol. Chem. 280 (2005) 8651-8659
19. Barish G.D., Downes M., Alaynick W.A., Yu R.T., Ocampo C.B., Bookout A.L., et al. A nuclear rreceptor atlas: macrophage activation. Mol. Endocrinol. 19 (2005) 2466-2477
20. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., et al. Interleukin-6-deficient mice develop mature-onset obesity. Nature Med. 8 (2002) 75-79
21. Xu L., Glass C.K., and Rosenfeld M.G. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9 (1999) 140-147
22. Renaud J.P., Harris J.M., Downes M., Burke L.J., and Muscat G.E. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains. Mol. Endocrinol. 14 (2000) 700-717
23. Bourguet W., Ruff M., Chambon P., Gronemeyer H., and Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 375 (1995) 377-382
24. Holm L., and Sander C. Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233 (1993) 123-138
25. Gampe Jr. R.T., Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K., Milburn M.V., et al. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell 5 (2000) 545-555
26. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395 (1998) 137-143
27. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 (1997) 753-758
28. Terenzi H., Alzari P.M., and Zakin M.M. Structural features involved in the formation of a complex between the monomeric or the dimeric form of the rev-erb beta DNA-binding domain and its DNA reactive sites. Biochemistry 37 (1998) 11488-11495
29. Kabsch W., and Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22 (1983) 2577-2637
30. Bourguet W., Vivat V., Wurtz J.M., Chambon P., Gronemeyer H., and Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell 5 (2000) 289-298
31. Wurtz J.M., Bourguet W., Renaud J.P., Vivat V., Chambon P., Moras D., and Gronemeyer H. A canonical structure for the ligand-binding domain of nuclear receptors. Nature Struct. Biol. 3 (1996) 206
32. Chrencik J.E., Orans J., Moore L.B., Xue Y., Peng L., Collins J.L., et al. Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin. Mol. Endocrinol. 19 (2005) 1125-1134
33. Downes M., Burke L.J., Bailey P.J., and Muscat G.E. Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors. Nucl. Acids Res. 24 (1996) 4379-4386
34. Xu H.E., Stanley T.B., Montana V.G., Lambert M.H., Shearer B.G., Cobb J.E., et al. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 415 (2002) 813-817
35. Reinking J., Lam M.M., Pardee K., Sampson H.M., Liu S., Yang P., et al. The Drosophila nuclear receptor e75 contains heme and is gas responsive. Cell 122 (2005) 195-207
36. Moran E., and Jimenez G. The tailless nuclear receptor acts as a dedicated repressor in the early Drosophila embryo. Mol. Cell. Biol. 26 (2006) 3446-3454
37. Wang Z., Benoit G., Liu J., Prasad S., Aarnisalo P., Liu X., et al. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 423 (2003) 555-560
38. Kallen J., Schlaeppi J.M., Bitsch F., Filipuzzi I., Schilb A., Riou V., et al. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha. J. Biol. Chem. 279 (2004) 49330-49337
39. Desclozeaux M., Krylova I.N., Horn F., Fletterick R.J., and Ingraham H.A. Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1. Mol. Cell. Biol. 22 (2002) 7193-7203
40. Boudjelal M., Wang Z., Voorhees J.J., and Fisher G.J. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes. Cancer Res. 60 (2000) 2247-2252
41. Yin L., Wang J., Klein P.S., and Lazar M.A. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science 311 (2006) 1002-1005
42. Stehlin-Gaon C., Willmann D., Zeyer D., Sanglier S., Van Dorsselaer A., Renaud J.P., et al. All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nature Struct. Biol. 10 (2003) 820-825
43. Watkins R.E., Wisely G.B., Moore L.B., Collins J.L., Lambert M.H., Williams S.P., et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 292 (2001) 2329-2333
44. Huang W., Zhang J., Wei P., Schrader W.T., and Moore D.D. Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR. Mol. Endocrinol. 18 (2004) 2402-2408
45. Farnegardh M., Bonn T., Sun S., Ljunggren J., Ahola H., Wilhelmsson A., et al. The three-dimensional structure of the liver X receptor beta reveals a flexible ligand-binding pocket that can accommodate fundamentally different ligands. J. Biol. Chem. 278 (2003) 38821-38828
46. Dhe-Paganon S., Duda K., Iwamoto M., Chi Y.I., and Shoelson S.E. Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand. J. Biol. Chem. 277 (2002) 37973-37976
47. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
48. Terwilliger T.C., and Berendzen J. Automated MAD and MIR structure solution. Acta Crystallog. sect. D 55 (1999) 849-861
49. Sheldrick G. SHELXL-97 program for crystal structure refinement. Tammanstrasse 4 (1997) D-3400
50. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A 47 (1991) 110-119
51. Laskowski R.A., Moss D.S., and Thornton J.M. Main-chain bond lengths and bond angles in protein structures. J. Mol. Biol. 231 (1993) 1049-1067
52. Perissi V., Staszewski L.M., McInerney E.M., Kurokawa R., Krones A., Rose D.W., et al. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13 (1999) 3198-3208
53. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl. Acids Res. 22 (1994) 4673-4680